NewYork Presbyterian Hospital/Weill Cornell Medical Center

Latest stories

14d
CNBC
New cholesterol drugs could add $120 billion to annual US health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual US health costs
CNBC / Posted 14 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories
14d
Detroit Free Press
New cholesterol drugs could add $120 billion to annual U.S. health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual U.S. health costs
Detroit Free Press / Posted 14 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories
14d
USA Today
New cholesterol drugs could add $120 billion to annual U.S. health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual U.S. health costs
USA Today / Posted 14 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories
15d
The San Angelo Standard-Times
New cholesterol drugs could add $120 billion to annual U.S. health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual U.S. health costs
The San Angelo Standard-Times / Posted 15 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories
15d
The Record Searchlight
New cholesterol drugs could add $120 billion to annual U.S. health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual U.S. health costs
The Record Searchlight / Posted 15 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories
15d
11 News Houston
New cholesterol drugs could add $120 billion to annual U.S. health costsare high-risk patients who are in grave danger who need PCSK9 inhibitors now,"
New cholesterol drugs could add $120 billion to annual U.S. health costs
11 News Houston / Posted 15 days ago
are high-risk patients who are in grave danger who need PCSK9 inhibitors now," said Patterson, chief operating officer at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "But they're really a handful of patients." Studies evaluating... Read more
7 related stories

People in this news